USANA
November 3, 2026
SALT LAKE CITY, Utah - November 3, 2026
USANA Health Sciences reported third-quarter 2026 net sales of $206 million on November 3, down 4 percent from $214 million a year earlier, and lowered its full-year outlook as gains at its Hiya children's health subsidiary failed to offset a shrinking customer base in its core direct-selling business.
The Salt Lake City nutrition company posted a net loss attributable to USANA of $5.6 million, or $0.30 per diluted share, for the quarter ended October 3, compared with a loss of $6.5 million, or $0.36 per share, in the third quarter of 2025. Adjusted results showed a loss of $0.11 per share, versus a loss of $0.15 a year ago. Adjusted EBITDA fell 13 percent to $12.1 million. Currency movements helped reported sales by about $4 million; excluding that benefit, consolidated sales fell 5.6 percent. Sales were also down 8 percent from the second quarter.
The core network marketing business, which USANA calls Core Nutritional, generated $171 million in sales, down 3 percent in dollars and 6 percent in constant currency. Active customers in that business fell 8 percent year over year to 356,000. Active Brand Partners slipped to 162,000 from 168,000, and active Preferred Customers dropped to 194,000 from 220,000.
Asia Pacific, which accounts for about two-thirds of company sales, brought in $138 million, down 4 percent. Greater China, USANA's largest market, produced $94 million, up 1.4 percent in dollars but lower in local currency, and its customer count fell 9 percent to 192,000. North Asia sales dropped 18 percent to $14 million. Southeast Asia Pacific was the bright spot, with sales up 2 percent to $30 million and active customers up 3 percent from the prior quarter. The Americas and Europe region fell 11 percent to $33 million, with 73,000 active customers.
Hiya, the subscription-based children's vitamin brand in which USANA holds a 78.8 percent stake, posted sales of $32 million, up 2 percent from a year ago and 12 percent from the second quarter. Active monthly subscribers rose 18 percent sequentially to 195,500 after the company stepped up marketing spending, a move that weighed on the segment's margins. Hiya's sales through Target and Amazon more than doubled from the second quarter. Rise Wellness, the protein bar and snack business, saw sales fall 45 percent to $4 million.
"As we continue our transformation to an omnichannel health and wellness company, our third quarter results were mixed, with meaningful improvement in some areas and results that fell short of our expectations in others," said Chairman and Chief Executive Officer Kevin Guest. He said rebuilding the Core Nutritional active customer base is the company's top priority and its single largest growth lever. USANA said it is changing its Brand Partner incentive plan to more directly reward growth in active customers, investing in digital marketing for the USANA brand, and preparing new products to begin rolling out in 2027.
USANA now expects 2026 consolidated net sales approaching $900 million, down from its earlier forecast of $910 million, and adjusted EBITDA of $77 million versus $80.5 million previously. Adjusted earnings guidance was cut to $0.55 per share from $0.76, and the company now projects a full-year net loss of $16 million, or $0.90 per share. Core Nutritional sales are forecast at $740 million, Hiya at $130 million, and Rise Wellness at $30 million.
The company also disclosed that it had overstated second-quarter adjusted EBITDA attributable to USANA. A $29.1 million Hiya goodwill impairment had been added back in full rather than net of the $6.2 million share belonging to Hiya's minority owners. The correction lowered second-quarter adjusted EBITDA to $21.7 million from $27.8 million and reduced the August outlook to $80.5 million from $86.7 million. USANA said the error affected only the non-GAAP measure and not its reported GAAP results.
USANA ended the quarter with $179 million in cash and no debt, generated $8 million in free cash flow during the quarter and $36 million year to date, and cut inventory 13 percent from the end of 2025. It did not buy back any shares in the quarter and has about $34 million left under its repurchase authorization. Shares fell about 10 percent in after-hours trading following the release.
USANA, founded in 1992, develops and manufactures nutritional supplements, functional foods, and personal care products sold through independent Brand Partners and Preferred Customers in 25 markets.